Insights into heart failure hospitalizations, management, and services during and beyond COVID‐19

SJ Charman, L Velicki, NC Okwose… - ESC heart …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory
syndrome coronavirus‐2. The clinical presentation of this virus mainly manifests in the …

SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study

R Laxminarayan, TG Vinay, KVA Kumar… - The Lancet Infectious …, 2021 - thelancet.com
Background SARS-CoV-2 has spread substantially within India over multiple waves of the
ongoing COVID-19 pandemic. However, the risk factors and disease burden associated with …

[HTML][HTML] COVID-19–related clinical outcomes among Korean hemodialysis patients

HC Park, YK Lee, E Ko, S Yu, AJ Cho… - Kidney Research and …, 2022 - ncbi.nlm.nih.gov
Background Hemodialysis (HD) patients are more vulnerable to viral epidemics,
experiencing higher mortality rates compared to individuals without chronic kidney disease …

How universities entrust digital literacy to improve student learning outcomes during the COVID-19 disruption

A Basir, K Kamaliah, A Harahap… - Jurnal Iqra' …, 2021 - journal.iaimnumetrolampung.ac.id
Since the policy of sending students home to study as a result of responding to the dangers
of the pandemic, universities around the world have increasingly trusted distance learning …

Renin angiotensin system blockers and risk of mortality in hypertensive patients hospitalized for COVID-19: an Italian registry

F Angeli, P Verdecchia, A Balestrino, C Bruschi… - Journal of …, 2022 - mdpi.com
Background: It is uncertain whether exposure to renin–angiotensin system (RAS) modifiers
affects the severity of the new coronavirus disease 2019 (COVID-19) because most of the …

Multimorbidity patterns in COVID-19 patients and their relationship with infection severity: MRisk-COVID study

M Lleal, C Corral-Vazquez, M Baré, R Comet… - Plos one, 2023 - journals.plos.org
Background Several chronic conditions have been identified as risk factors for severe
COVID-19 infection, yet the implications of multimorbidity need to be explored. The objective …

Updated recommendations on cardiovascular prevention in 2022: an executive document of the Italian Society of Cardiovascular Prevention

M Volpe, G Gallo, MG Modena, C Ferri… - High Blood Pressure & …, 2022 - Springer
This executive document reflects and updates the key points of a Consensus document on
Cardiovascular (CV) Prevention realized through the contribution of a number of Italian …

Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis

MY Alsagaff, EPB Mulia, I Maghfirah, K Luke… - Diabetes & Metabolic …, 2021 - Elsevier
Aims This meta-analysis aims to analyze the association of calcium channel blocker (CCB)
use with COVID-19 clinical outcomes. Methods PubMed, ProQuest, Science Direct, Scopus …

Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study

FTT Lai, VKC Yan, X Ye, T Ma, X Qin, CSL Chui, X Li… - Cmaj, 2023 - Can Med Assoc
Background: Multimorbidity is a prevalent risk factor for COVID-19–related complications
and death. We sought to evaluate the association of homologous booster vaccination using …

Management of anaphylaxis due to COVID‐19 vaccines in the elderly

J Bousquet, I Agache, H Blain, M Jutel, MT Ventura… - Allergy, 2021 - Wiley Online Library
Older adults, especially men and/or those with diabetes, hypertension, and/or obesity, are
prone to severe COVID‐19. In some countries, older adults, particularly those residing in …